BCL2 and cancer: Since the original characterisation of the (14;18) translocation in lymphoma, Bcl-2 protein expression has been found to be elevated in a range of cancers, including chronic lymphocytic leukaemia (CLL)16, small cell lung carcinoma (SCLC)17 and neuroblastoma18.